CNMV - Other relevant information

Cookies notice

This website uses its own cookies and third-party cookies for technical, customisation, and analysis of behavioural advertising purposes. The latter provides data regarding browsing habits (such as the pages visited) and determine profiles to improve our content.

For further information, please read our Cookies Policy

This website contains links from third-party websites that may contain cookies not belonging to the CNMV. By viewing and accessing them, you accept the cookies installed by third parties and their corresponding privacy and cookies policy.

This website uses cookies and/or similar technologies that store and retrieve information when browsing. For further information, see our Cookies Policy

Technical cookies

Used for the website’s proper functioning.

Customisation cookies

They retrieve information in order for the user to access the service with certain characteristics that may change their experience from that of other users. For example, the language selected or other options that allow for an improved accessibility within the website.

Analytics cookies

Third party (Google). These allow for follow-up and user behaviour analysis for the purpose of incorporating improvements to the website’s content.

Behavioural advertising cookies

Third party (Google). They store information on user behaviour obtained through ongoing observation of their browsing habits, allowing for the development of a specific profile for information content optimisation.

Page 26 out of 27

last 30 days

- 03/08/2026
- 13:09
- AUTO ABS SPANISH LOANS 2022-01, FONDO DE TITULIZACION
- On securitisation funds
- INFORMACION FECHA DE PAGO DEL FONDO AUTO ABS SPANISH LOANS 2022-01, FONDO DE TITULIZACION
- Register number: 42304
- 03/08/2026
- 13:07
- PHARMA MAR, S.A.
- Share buy-back , stabilisation and treasury stock programmes
- The Company reports on treasury share acquisitions in the period from July 1 to July 31, 2026.
- Register number: 42303
- 03/08/2026
- 13:04
- AYT GENOVA HIPOTECARIO X, FONDO DE TITULIZACION HIPOTECARIA
- On securitisation funds
- Liquidación Anticipada AyT Génova Hipotecario X, FTH
- Register number: 42302
- 03/08/2026
- 12:54
- PRIM, S.A.
- Share buy-back , stabilisation and treasury stock programmes
- OPERACIONES REALIZADAS AL AMPARO DEL PROGRAMA DE RECOMPRA ENTRE EL 24/07 Y EL 31/07
- Register number: 42301
- 03/08/2026
- 12:36
- NEINOR HOMES, S.A.
- Share buy-back , stabilisation and treasury stock programmes
- Share Buy-Back details - (July 27 to July 31)
- Register number: 42300
- 03/08/2026
- 11:30
- INDRA SISTEMAS, S.A.
- Liquidity and counterparty agreements
- Liquidity program: regular information (May 1th, 2026-July 31th, 2026)
- Register number: 42299
- 03/08/2026
- 11:27
- VIDRALA, S.A.
- Share buy-back , stabilisation and treasury stock programmes
- VIDRALA reports the transactions carried out under its share buy-back programme between 27 and 31 July 2026.
- Register number: 42298
- 03/08/2026
- 11:10
- SABADELL CONSUMO 2, FONDO DE TITULIZACION
- On securitisation funds
- Revisión calificaciones Bonos por DBRS
- Register number: 42297
- - Notification modified by communication number 41936 dated 17/07/2026 (10:39)
- 03/08/2026
- 08:40
- LINGOTES ESPECIALES, S.A.
- On business and financial situation
- Avance de resultados primer semestre 2026
- Register number: 42296
- 03/08/2026
- 08:33
- PHARMA MAR, S.A.
- On business and financial situation
- Health authorities in Canada, Qatar and South Korea approve PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) combination as first-line maintenance therapy for extensive-stage small cell lung cancer.
- Register number: 42295

Page 26 out of 27